{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:22:31Z","timestamp":1792142551433,"version":"4.4.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/nrendo.2014.170","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T11:37:40Z","timestamp":1412681860000},"page":"711-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":410,"title":["Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications"],"prefix":"10.1038","volume":"10","author":[{"given":"Brian M.","family":"Frier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"BFnrendo2014170_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/9781118695432.ch4","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"MWJ Strachan","year":"2014","unstructured":"Strachan, M. W. J. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 4 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 63\u201395 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1464-5491.1991.tb01575.x","volume":"8","author":"S Pramming","year":"1991","unstructured":"Pramming, S., Thorsteinsson, B., Bendtson, I. & Binder, C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 8, 217\u2013222 (1991).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1464-5491.2006.01880.x","volume":"23","author":"K Akram","year":"2006","unstructured":"Akram, K., Pedersen-Bjergaard, U., Carstensen, B., Borch-Johnsen, K. & Thorsteinsson, B. Frequency and risk factors of severe hypoglycaemia in insulin-treated type 2 diabetes: a cross-sectional survey. Diabet. Med. 23, 750\u2013756 (2006).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2337\/diacare.26.4.1106","volume":"26","author":"H J\u00f8rgensen","year":"2003","unstructured":"J\u00f8rgensen, H., Pedersen-Bjergaard, U., Rasmussen, A. & Borch-Johnsen, K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 26, 1106\u20131109 (2003).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/9781118695432.ch9","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"JE Schopman","year":"2014","unstructured":"Schopman, J. E. & DeVries, J. H. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 9 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 184\u2013196 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2337\/diacare.25.9.1499","volume":"25","author":"K McGowan","year":"2002","unstructured":"McGowan, K., Thomas, W. & Moran, A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25, 1499\u20131503 (2002).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/dmrr.482","volume":"20","author":"U Pedersen-Bjergaard","year":"2004","unstructured":"Pedersen-Bjergaard, U. et al. Severe hypoglycaemia in 1,076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 20, 479\u2013486 (2004).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2014170_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","volume":"22","author":"LA Donnelly","year":"2005","unstructured":"Donnelly, L. A. et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet. Med. 22, 749\u2013755 (2005).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/dme.12261","volume":"31","author":"CG Ostenson","year":"2014","unstructured":"Ostenson, C. G. et al. Self-reported non-severe hypoglycaemic events in Europe. Diabet. Med. 31, 92\u2013101 (2014).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR10","doi-asserted-by":"crossref","unstructured":"Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245\u20131249 (2005).","DOI":"10.2337\/diacare.28.5.1245"},{"key":"BFnrendo2014170_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00125-008-1209-3","volume":"52","author":"BM Frier","year":"2009","unstructured":"Frier, B. M. Defining hypoglycaemia: what level has clinical relevance? Diabetologia 52, 31\u201334 (2009).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00125-008-1205-7","volume":"52","author":"PE Cryer","year":"2009","unstructured":"Cryer, P. E. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 52, 35\u201337 (2009).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00125-008-1147-0","volume":"52","author":"SG Swinnen","year":"2009","unstructured":"Swinnen, S. G., Mullins, P., Miller, M., Hoekstra, J. B. & Holleman, F. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia 52, 38\u201341 (2009).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1464-5491.2004.01250.x","volume":"21","author":"MK Bulsara","year":"2004","unstructured":"Bulsara, M. K., Holman, C. D., Davis, E. A. & Jones, T. W. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies\u2014what method should we use? Diabet. Med. 21, 914\u2013919 (2004).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR15","first-page":"1659","volume":"79","author":"DJ Cox","year":"1994","unstructured":"Cox, D. J. et al. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J. Clin. Endocrinol. Metab. 79, 1659\u20131662 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014170_CR16","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00125-007-0820-z","volume":"50","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick, E. S., Rigby, A. S., Goode, K. & Atkin, S. L. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 50, 2553\u20132561 (2007).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1089\/dia.2011.0049","volume":"13","author":"L Monnier","year":"2011","unstructured":"Monnier, L., Wojtusciszyn, A., Colette, C. & Owens, D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol. Ther. 13, 813\u2013818 (2011).","journal-title":"Diabetes Technol. Ther."},{"key":"BFnrendo2014170_CR18","doi-asserted-by":"crossref","unstructured":"[No authors listed] Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The DCCT Research Group. Am. J. Med. 90, 450\u2013459 (1991).","DOI":"10.1016\/0002-9343(91)90605-W"},{"key":"BFnrendo2014170_CR19","doi-asserted-by":"crossref","unstructured":"[No authors listed] The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977\u2013986 (1993).","DOI":"10.1056\/NEJM199309303291401"},{"key":"BFnrendo2014170_CR20","doi-asserted-by":"crossref","unstructured":"[No authors listed] Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46, 271\u2013286 (1997).","DOI":"10.2337\/diab.46.2.271"},{"key":"BFnrendo2014170_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1464-5491.1993.tb00051.x","volume":"10","author":"KM MacLeod","year":"1993","unstructured":"MacLeod, K. M., Hepburn, D. A. & Frier, B. M. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 10, 238\u2013245 (1993).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR22","doi-asserted-by":"crossref","unstructured":"[No authors listed] Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37, 278\u2013285 (1994).","DOI":"10.1007\/BF00398055"},{"key":"BFnrendo2014170_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2337\/diacare.23.10.1467","volume":"23","author":"EW ter Braak","year":"2000","unstructured":"ter Braak, E. W. et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23, 1467\u20131471 (2000).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR24","doi-asserted-by":"crossref","unstructured":"UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50, 1140\u20131147 (2007).","DOI":"10.1007\/s00125-007-0599-y"},{"key":"BFnrendo2014170_CR25","first-page":"186","volume":"29","author":"LA Leiter","year":"2005","unstructured":"Leiter, L. A. et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can. J. Diabetes 29, 186\u2013192 (2005).","journal-title":"Can. J. Diabetes"},{"key":"BFnrendo2014170_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s001250051065","volume":"41","author":"I M\u00fchlhauser","year":"1998","unstructured":"M\u00fchlhauser, I., Overmann, H., Bender, R., Bott, U. & Berger, M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes\u2014a prospective population based study. Diabetologia 41, 1274\u20131282 (1998).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.diabres.2011.10.046","volume":"96","author":"PL Kristensen","year":"2012","unstructured":"Kristensen, P. L. et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res. Clin. Pract. 96, 17\u201323 (2012).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrendo2014170_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00125-002-0969-4","volume":"46","author":"U Pedersen-Bjergaard","year":"2003","unstructured":"Pedersen-Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P. & Thorsteinsson, B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 46, 89\u201396 (2003).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR29","doi-asserted-by":"crossref","unstructured":"[No authors listed] Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 10, 1\u201319 (1987).","DOI":"10.2337\/diacare.10.1.1"},{"key":"BFnrendo2014170_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc07-1066","volume":"31","author":"LR Nielsen","year":"2008","unstructured":"Nielsen, L. R. et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31, 9\u201314 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1464-5491.1993.tb00050.x","volume":"10","author":"DA Hepburn","year":"1993","unstructured":"Hepburn, D. A., MacLeod, K. M., Pell, A. C., Scougal, I. J. & Frier, B. M. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10, 231\u2013237 (1993).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1046\/j.1464-5491.2003.01072.x","volume":"20","author":"JN Henderson","year":"2003","unstructured":"Henderson, J. N., Allen, K. V., Deary, I. J. & Frier, B. M. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet .Med. 20, 1016\u20131021 (2003).","journal-title":"Diabet .Med."},{"key":"BFnrendo2014170_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4158\/EP.9.6.530","volume":"9","author":"KV Allen","year":"2003","unstructured":"Allen, K. V. & Frier, B. M. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr. Pract. 9, 530\u2013543 (2003).","journal-title":"Endocr. Pract."},{"key":"BFnrendo2014170_CR34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/9781118695432.ch5","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"E Chow","year":"2014","unstructured":"Chow, E. & Heller, S. R. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 5 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 96\u2013113 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR35","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1111\/j.1464-5491.2012.03681.x","volume":"29","author":"M Sch\u00fctt","year":"2012","unstructured":"Sch\u00fctt, M. et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with type 1 diabetes. Diabet. Med. 29, e176\u2013e179 (2012).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/9781118695432.ch10","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"KA Matyka","year":"2014","unstructured":"Matyka, K. A. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 10 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 197\u2013217 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/9781118695432.ch12","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"NN Zammitt","year":"2014","unstructured":"Zammitt, N. N. & Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 12 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 230\u2013262 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR38","doi-asserted-by":"crossref","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545\u20132559 (2008).","DOI":"10.1056\/NEJMoa0802743"},{"key":"BFnrendo2014170_CR39","doi-asserted-by":"crossref","unstructured":"ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560\u20132572 (2008).","DOI":"10.1056\/NEJMoa0802987"},{"key":"BFnrendo2014170_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129\u2013139 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2014170_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/bmj.301.6755.783","volume":"301","author":"RE Ryder","year":"1990","unstructured":"Ryder, R. E., Owens, D. R., Hayes, T. M., Ghatei, M. A. & Bloom, S. R. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 301, 783\u2013787 (1990).","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"BFnrendo2014170_CR42","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/S1262-3636(10)70470-5","volume":"36","author":"AJ Graveling","year":"2010","unstructured":"Graveling, A. J. & Frier, B. M. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 36 (Suppl. 3), S64\u2013S74 (2010).","journal-title":"Diabetes Metab."},{"key":"BFnrendo2014170_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMra1215228","volume":"369","author":"PE Cryer","year":"2013","unstructured":"Cryer, P. E. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 369, 362\u2013372 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2014170_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198303033080903","volume":"308","author":"NH White","year":"1983","unstructured":"White, N. H. et al. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N. Engl. J. Med. 308, 485\u2013491 (1983).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2014170_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diacare.17.7.697","volume":"17","author":"AE Gold","year":"1994","unstructured":"Gold, A. E., MacLeod, K. M. & Frier, B. M. Frequency of severe hypoglycemia in patients with impaired awareness of hypoglycemia. Diabetes Care 17, 697\u2013703 (1994).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1464-5491.2008.02413.x","volume":"25","author":"J Geddes","year":"2008","unstructured":"Geddes, J., Schopman, J. E., Zammitt, N. N. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501\u2013504 (2008).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.diabres.2009.10.013","volume":"87","author":"JE Schopman","year":"2010","unstructured":"Schopman, J. E., Geddes, J. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 87, 64\u201368 (2010).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrendo2014170_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2337\/diacare.14.4.344","volume":"14","author":"I M\u00fchlhauser","year":"1991","unstructured":"M\u00fchlhauser, I., Toth, G., Sawicki, P. T. & Berger, M. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diabetes Care 14, 344\u2013346 (1991).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR49","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1210\/jc.2009-2828","volume":"95","author":"TM Davis","year":"2010","unstructured":"Davis, T. M. et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J. Clin. Endocrinol. Metab. 95, 2240\u20132247 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2014170_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1096-9136(199704)14:4<309::AID-DIA345>3.0.CO;2-#","volume":"14","author":"AE Gold","year":"1997","unstructured":"Gold, A. E., Frier, B. M., MacLeod, K. M. & Deary, I. J. A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus. Diabet. Med. 14, 309\u2013315 (1997).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2337\/dc11-1855","volume":"35","author":"Z Punthakee","year":"2012","unstructured":"Punthakee, Z. et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 35, 787\u2013793 (2012).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3109\/00365513.2011.604132","volume":"71","author":"L Faerch","year":"2011","unstructured":"Faerch, L., Pedersen-Bjergaard, U. & Thorsteinsson, B. High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes. Scand. J. Clin. Lab. Med. 71, 620\u2013624 (2011).","journal-title":"Scand. J. Clin. Lab. Med."},{"key":"BFnrendo2014170_CR53","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00125-007-0613-4","volume":"50","author":"MK Bulsara","year":"2007","unstructured":"Bulsara, M. K. et al. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes. Diabetologia 50, 965\u2013971 (2007).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR54","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/j.1464-5491.2007.02263.x","volume":"24","author":"NN Zammitt","year":"2007","unstructured":"Zammitt, N. N. et al. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in type 1 diabetes: does a relationship exist? Diabet. Med. 24, 1449\u20131454 (2007).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR55","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1046\/j.1464-5491.2001.00620.x","volume":"18","author":"V McAulay","year":"2001","unstructured":"McAulay, V., Deary, I. J. & Frier, B. M. Symptoms of hypoglycaemia in people with diabetes. Diabet. Med. 18, 690\u2013705 (2001).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0031-9384(99)00035-9","volume":"67","author":"RJ McCrimmon","year":"1999","unstructured":"McCrimmon, R. J., Frier, B. M. & Deary, I. J., Appraisal of mood and personality during hypoglycaemia in human subjects. Physiol. Behav. 67, 27\u201333 (1999).","journal-title":"Physiol. Behav."},{"key":"BFnrendo2014170_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1474651412466273","volume":"12","author":"B Inkster","year":"2012","unstructured":"Inkster, B. & Frier, B. M. The effects of acute hypoglycaemia on cognitive function in type 1 diabetes. Br. J. Diabetes Vasc. Dis. 12, 221\u2013226 (2012).","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"BFnrendo2014170_CR58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/dom.12071","volume":"15","author":"B Inkster","year":"2013","unstructured":"Inkster, B. & Frier, B. M. Driving and diabetes. Diabetes Obes. Metab. 15, 775\u2013783 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"BFnrendo2014170_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pcd.2009.08.007","volume":"3","author":"AJ Graveling","year":"2009","unstructured":"Graveling, A. J. & Frier, B. M. Hypoglycaemia: an overview. Prim. Care Diabetes 3, 131\u2013139 (2009).","journal-title":"Prim. Care Diabetes"},{"key":"BFnrendo2014170_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/dmrr.796","volume":"24","author":"BM Frier","year":"2008","unstructured":"Frier, B. M. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab. Res. Rev. 24, 87\u201392 (2008).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2014170_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/9781118695432","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"BM Frier","year":"2014","unstructured":"Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 18 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 347\u2013368 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pec.2007.05.003","volume":"68","author":"D Wild","year":"2007","unstructured":"Wild, D. et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns. 68, 10\u201315 (2007).","journal-title":"Patient Educ. Couns."},{"key":"BFnrendo2014170_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1464-5491.2011.03416.x","volume":"29","author":"S Barendse","year":"2012","unstructured":"Barendse, S., Singh, H., Frier, B. M. & Speight, J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative review. Diabet. Med. 29, 293\u2013302 (2012).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR64","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2337\/diacare.28.6.1333","volume":"28","author":"AM Leckie","year":"2005","unstructured":"Leckie, A. M., Graham, M. K., Grant, J. B., Ritchie, P. J. & Frier, B. M. Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care 28, 1333\u20131338 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007995.2012.652420","volume":"28","author":"M Brod","year":"2012","unstructured":"Brod, M., Rana, A. & Barnett, A. H. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr. Med. Res. Opin. 28, 1\u201312 (2012).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnrendo2014170_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/dc13-1154","volume":"37","author":"J Lawton","year":"2014","unstructured":"Lawton, J. et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 37, 109\u2013115 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"RJ Wright","year":"2008","unstructured":"Wright, R. J. & Frier, B. M. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab. Res. Rev. 24, 353\u2013363 (2008).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2014170_CR68","doi-asserted-by":"publisher","first-page":"E1274","DOI":"10.1152\/ajpendo.00114.2007","volume":"293","author":"AJ Sommerfield","year":"2007","unstructured":"Sommerfield, A. J., Wilkinson, I. B., Webb, D. J. & Frier, B. M. Vessel wall stiffness in type 1 diabetes, and the central hemodynamic effects of acute hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 293, E1274\u2013E1279 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo2014170_CR69","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/CIRCULATIONAHA.110.992297","volume":"124","author":"O Rana","year":"2011","unstructured":"Rana, O. et al. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation 124, 1548\u20131556 (2011).","journal-title":"Circulation"},{"key":"BFnrendo2014170_CR70","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1464-5491.1992.tb01834.x","volume":"9","author":"T Lindstr\u00f6m","year":"1992","unstructured":"Lindstr\u00f6m, T., Jorfeldt, L., Tegler, L. & Arnqvist, H. J. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet. Med. 9, 536\u2013541 (1992).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR71","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","volume":"26","author":"C Desouza","year":"2003","unstructured":"Desouza, C., Salazar, H., Cheong, B., Murgo, J. & Fonseca, V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 26, 1485\u20131489 (2003).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR72","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-007-0902-y","volume":"51","author":"ML Koivikko","year":"2008","unstructured":"Koivikko, M. L. et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia 51, 426\u2013435 (2008).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR73","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2337\/diabetes.52.6.1469","volume":"52","author":"RT Robinson","year":"2003","unstructured":"Robinson, R. T. et al. Mechanisms of abnormal cardiac repolarisation during insulin-induced hypoglycemia. Diabetes 52, 1469\u20131474 (2003).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00125-008-1177-7","volume":"52","author":"GV Gill","year":"2009","unstructured":"Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes\u2014the 'dead in bed' syndrome revisited. Diabetologia 52, 42\u201345 (2009).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR75","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2337\/dc13-0600","volume":"37","author":"A Stahn","year":"2014","unstructured":"Stahn, A. et al. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care 37, 516\u2013520 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR76","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2337\/db13-0468","volume":"63","author":"E Chow","year":"2014","unstructured":"Chow, E. et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63, 1738\u20131747 (2014).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR77","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJM199806043382303","volume":"338","author":"TW Jones","year":"1998","unstructured":"Jones, T. W. et al. Decreased epinephrine responses to hypoglycemia during sleep. N. Engl. J. Med. 338, 1657\u20131662 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2014170_CR78","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.2337\/db13-0216","volume":"62","author":"CM Reno","year":"2013","unstructured":"Reno, C. M. et al. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 62, 3570\u20133581 (2013).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR79","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/diabetes.53.6.1535","volume":"53","author":"SP Lee","year":"2004","unstructured":"Lee, S. P. et al. Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes. Diabetes 53, 1535\u20131542 (2004).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR80","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.metabol.2012.12.003","volume":"62","author":"N Soydan","year":"2013","unstructured":"Soydan, N. et al. Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 62, 717\u2013724 (2013).","journal-title":"Metabolism"},{"key":"BFnrendo2014170_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1464-5491.1991.tb01516.x","volume":"8","author":"RB Tattersall","year":"1991","unstructured":"Tattersall, R. B. & Gill, G. V. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 8, 49\u201358 (1991).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR82","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4158\/EP09260.CR","volume":"16","author":"RJ Tanenberg","year":"2010","unstructured":"Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the 'dead-in-bed' syndrome as captured by a retrospective continuous glucose monitoring system. Endocr. Pract 16, 244\u2013248 (2010).","journal-title":"Endocr. Pract"},{"key":"BFnrendo2014170_CR83","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/dc13-0701","volume":"37","author":"T Tsujimoto","year":"2014","unstructured":"Tsujimoto, T. et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37, 217\u2013225 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR84","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(85)92692-3","volume":"326","author":"BM Frier","year":"1985","unstructured":"Frier, B. M. & Hilsted, J. Does hypoglycaemia aggravate the complications of diabetes? Lancet 326, 1175\u20131177 (1985).","journal-title":"Lancet"},{"key":"BFnrendo2014170_CR85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc10-1371","volume":"34","author":"M Giminez","year":"2011","unstructured":"Giminez, M. et al. Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes. Diabetes Care 34, 198\u2013203 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR86","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2337\/dc10-0013","volume":"33","author":"RJ Wright","year":"2010","unstructured":"Wright, R. J. et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation. Diabetes Care 33, 1591\u20131597 (2010).","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"BFnrendo2014170_CR87","first-page":"S243","volume":"56","author":"EYK Chow","year":"2013","unstructured":"Chow, E. Y. K., Iqbal, A., Phoenix, F., Heller, S. R. & Ajjan, R. A. Hypoglycaemia promotes thrombosis and inflammation for at least one week in patients with type 2 diabetes [abstract]. Diabetologia 56 (Suppl. 1), S243 (2013).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR88","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/cs0890359","volume":"89","author":"AM Robinson","year":"1995","unstructured":"Robinson, A. M. et al. Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clin. Sci. (Lond.) 89, 359\u2013366 (1995).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrendo2014170_CR89","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2337\/db08-1153","volume":"58","author":"GK Adler","year":"2009","unstructured":"Adler, G. K. et al. Antecedent hypoglycemia impairs autonomic cardiovascular function. Implications for rigorous glycemic control. Diabetes 58, 360\u2013366 (2009).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR90","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","volume":"383","author":"G Heusch","year":"2014","unstructured":"Heusch, G. et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383, 1933\u20131943 (2014).","journal-title":"Lancet"},{"key":"BFnrendo2014170_CR91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10354-010-0748-7","volume":"160","author":"G Schernthaner","year":"2010","unstructured":"Schernthaner, G. Diabetes and cardiovascular disease: is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien. Med. Wochenschr. 160, 8\u201319 (2010).","journal-title":"Wien. Med. Wochenschr."},{"issue":"Suppl. 2","key":"BFnrendo2014170_CR92","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.2337\/dc11-s220","volume":"34","author":"BM Frier","year":"2011","unstructured":"Frier, B. M., Schernthaner, G. & Heller, S. R. Hypoglycemia and cardiovascular risks. Diabetes Care 34 (Suppl. 2), S132\u2013S137 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR93","doi-asserted-by":"publisher","first-page":"b4909","DOI":"10.1136\/bmj.b4909","volume":"340","author":"DE Bonds","year":"2010","unstructured":"Bonds, D. E. et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340, b4909 (2010).","journal-title":"BMJ"},{"key":"BFnrendo2014170_CR94","doi-asserted-by":"crossref","unstructured":"ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN Trial. Eur. Heart J. 34, 3137\u20133144 (2013).","DOI":"10.1093\/eurheartj\/eht332"},{"key":"BFnrendo2014170_CR95","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2337\/diacare.26.4.1176","volume":"26","author":"GP Leese","year":"2003","unstructured":"Leese, G. P. et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. A population-based study of health service resource use. Diabetes Care 26, 1176\u20131180 (2003).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR96","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1463-1326.2004.00421.x","volume":"7","author":"RE Warren","year":"2005","unstructured":"Warren, R. E. & Frier, B. M. Hypoglycaemia and cognitive function. Diabetes Obes. Metab. 7, 493\u2013503 (2005).","journal-title":"Diabetes Obes. Metab."},{"key":"BFnrendo2014170_CR97","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2337\/db07-0695","volume":"57","author":"NN Zammitt","year":"2008","unstructured":"Zammitt, N. N., Warren, R. E., Deary, I. J. & Frier, B. M. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Effect of impaired awareness of hypoglycemia. Diabetes 57, 732\u2013736 (2008).","journal-title":"Diabetes"},{"key":"BFnrendo2014170_CR98","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/(SICI)1096-9136(199801)15:1<30::AID-DIA526>3.0.CO;2-R","volume":"15","author":"M Bjorgaas","year":"1998","unstructured":"Bjorgaas, M., Sand, T., Vik, T. & Jorde, R. Quantitative EEG during controlled hypoglycaemia in diabetic and nondiabetic children. Diabet. Med. 15, 30\u201337 (1998).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/9781118695432.ch15","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"P Perros","year":"2014","unstructured":"Perros, P. & Bjorgaas, M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 15 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 305\u2013322 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR100","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0026-0495(92)90310-7","volume":"41","author":"G Tallroth","year":"1992","unstructured":"Tallroth, G., Ryding, E. & Agardh, C. D. Regional cerebral blood flow in normal man during insulin-induced hypoglycemia and in the recovery period following glucose infusion. Metabolism 41, 717\u2013721 (1992).","journal-title":"Metabolism"},{"key":"BFnrendo2014170_CR101","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.jcbfm.9600045","volume":"25","author":"RP Kennan","year":"2005","unstructured":"Kennan, R. P., Takahashi, K., Pan, C., Shamoon, H. & Pan, J. W. Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia. J. Cereb. Blood Flow Metab. 25, 527\u2013534 (2005).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrendo2014170_CR102","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF00398052","volume":"37","author":"KM MacLeod","year":"1994","unstructured":"MacLeod, K. M. et al. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37, 257\u2013263 (1994).","journal-title":"Diabetologia"},{"key":"BFnrendo2014170_CR103","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0026-0495(96)90266-8","volume":"45","author":"KM MacLeod","year":"1996","unstructured":"MacLeod, K. M. et al. The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type 1 (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45, 974\u2013980 (1996).","journal-title":"Metabolism"},{"key":"BFnrendo2014170_CR104","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2337\/diacare.14.10.922","volume":"14","author":"J Chalmers","year":"1991","unstructured":"Chalmers, J. et al. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlates. Diabetes Care 14, 922\u2013925 (1991).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR105","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/01.STR.0000155733.65215.c2","volume":"36","author":"J Bottcher","year":"2005","unstructured":"Bottcher, J. et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36, e20\u2013e22 (2005).","journal-title":"Stroke"},{"key":"BFnrendo2014170_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1212\/01.wnl.0000167128.14769.7b","volume":"65","author":"C Cordonnier","year":"2005","unstructured":"Cordonnier, C. et al. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 65, 175 (2005).","journal-title":"Neurology"},{"key":"BFnrendo2014170_CR107","first-page":"3","volume":"3","author":"AM Arbelaez","year":"2010","unstructured":"Arbelaez, A. M. & Hershey, T. Imaging hypoglycemia's effects on the human brain. Diabetic Hypoglycemia 3, 3\u20139 (2010).","journal-title":"Diabetic Hypoglycemia"},{"key":"BFnrendo2014170_CR108","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2337\/dc10-0621","volume":"33","author":"BO Asvold","year":"2010","unstructured":"Asvold, B. O., Sand, T., Hestad, K. & Bjorgaas, M. R. Cognitive function in type 1 diabetic adults with childhood exposure to severe hypoglycemia: a 16 year follow-up study. Diabetes Care 33, 1945\u20131947 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR109","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.2337\/dc11-0697","volume":"34","author":"TT Ly","year":"2011","unstructured":"Ly, T. T., Anderson, M., McNamara, K. T., Davis, E. A. & Jones, T. W. Neurocognitive outcomes in young adults with early-onset type 1 diabetes. Diabetes Care 34, 2192\u20132197 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR110","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2337\/dc08-1657","volume":"32","author":"EA Northam","year":"2009","unstructured":"Northam, E. A. et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32, 445\u2013450 (2009).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR111","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842\u20131852 (2007).","DOI":"10.1056\/NEJMoa066397"},{"key":"BFnrendo2014170_CR112","first-page":"11","volume":"6","author":"GJ Biessels","year":"2014","unstructured":"Biessels, G. J. Hypoglycemia and cognitive decline in older people with type 2 diabetes: a bidirectional relationship. Diabetic Hypoglycemia 6, 11\u201314 (2014).","journal-title":"Diabetic Hypoglycemia"},{"key":"BFnrendo2014170_CR113","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jamainternmed.2013.6176","volume":"173","author":"K Yaffe","year":"2013","unstructured":"Yaffe, K. et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern. Med. 173, 1300\u20131306 (2013).","journal-title":"JAMA Intern. Med."},{"key":"BFnrendo2014170_CR114","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/dc13-1384","volume":"37","author":"I Feinkohl","year":"2014","unstructured":"Feinkohl, I. et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 37, 507\u2013515 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9781118695432.ch14","volume-title":"Hypoglycaemia in Clinical Diabetes","author":"CM Ryan","year":"2014","unstructured":"Ryan, C. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 14 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 285\u2013304 (Wiley Blackwell, 2014)."},{"key":"BFnrendo2014170_CR116","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc12-2480","volume":"36","author":"ER Seaquist","year":"2013","unstructured":"Seaquist, E. R. et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384\u20131395 (2013).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR117","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/dc06-1386","volume":"30","author":"DJ Cox","year":"2007","unstructured":"Cox, D. J., Gonder-Frederick, L., Ritterband, L., Clarke, W. & Kovatchev, B. P. Prediction of severe hypoglycemia. Diabetes Care 30, 1370\u20131373 (2007).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR118","doi-asserted-by":"publisher","unstructured":"Siebenhofer, A. et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003287. http:\/\/dx.doi.org\/10.1002\/14651858.CD003287.pub4 .","DOI":"10.1002\/14651858.CD003287.pub4"},{"key":"BFnrendo2014170_CR119","doi-asserted-by":"publisher","unstructured":"Horvath, K. et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD005613. http:\/\/dx.doi.org\/10.1002\/14651858.CD005613.pub3 .","DOI":"10.1002\/14651858.CD005613.pub3"},{"key":"BFnrendo2014170_CR120","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/14740338.2012.694424","volume":"11","author":"B Inkster","year":"2012","unstructured":"Inkster, B., Zammitt, N. N. & Frier, B. M. Drug-induced hypoglycaemia in type 2 diabetes. Expert Opin. Drug Saf. 11, 597\u2013614 (2012).","journal-title":"Expert Opin. Drug Saf."},{"key":"BFnrendo2014170_CR121","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/dia.2005.7.440","volume":"7","author":"B Buckingham","year":"2005","unstructured":"Buckingham, B. et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol. Ther. 7, 440\u2013447 (2005).","journal-title":"Diabetes Technol. Ther."},{"key":"BFnrendo2014170_CR122","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.2337\/dc13-0939","volume":"36","author":"P Choudhary","year":"2013","unstructured":"Choudhary, P. et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 36, 4160\u20134162 (2013).","journal-title":"Diabetes Care"},{"key":"BFnrendo2014170_CR123","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1262-3636(08)73972-7","volume":"34","author":"H Hanaire","year":"2008","unstructured":"Hanaire, H. et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab. 34, 401\u2013423 (2008).","journal-title":"Diabetes Metab."},{"key":"BFnrendo2014170_CR124","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","volume":"25","author":"JC Pickup","year":"2008","unstructured":"Pickup, J. C. & Sutton, A. J. Severe hypoglycaemia and glycaemic control in type 1 diabetes; meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet. Med. 25, 765\u2013774 (2008).","journal-title":"Diabet. Med."},{"key":"BFnrendo2014170_CR125","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2011.32","volume":"7","author":"R Hovorka","year":"2011","unstructured":"Hovorka, R. Closed-loop insulin delivery: from bench to clinical practice. Nat. Rev. Endocrinol. 7, 385\u2013395 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrendo2014170_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.diabres.2013.09.009","volume":"102","author":"E Renard","year":"2013","unstructured":"Renard, E., Cobelli, C. & Kovatchev, B. P. Closed loop developments to improve glucose control at home. Diabetes Res. Clin. Pract. 102, 79\u201385 (2013).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrendo2014170_CR127","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2013.277818","volume":"310","author":"TT Ly","year":"2013","unstructured":"Ly, T. T. et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes. A randomized clinical trial. JAMA 310, 1240\u20131247 (2013).","journal-title":"JAMA"},{"key":"BFnrendo2014170_CR128","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1303576","volume":"369","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal, R. M. et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 369, 224\u2013232 (2013).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.170","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2014.170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:46:23Z","timestamp":1717425983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2014.170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":128,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFnrendo2014170"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2014.170","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"assertion":[{"value":"7 October 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has received honoraria for giving lectures at scientific meetings arranged by Boehringer Ingelheim, Eli Lilly, Janssen, MSD, Novo Nordisk and Sanofi, and as a member of scientific advisory boards for the same pharmaceutical companies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}